INFANT PHOTOTHERAPY – SEEFAR AND SAPPHIRE

Neonatal Care – LED PHOTOTHERAPY

In the phototherapy process, LED light has a comparable impact to that of fluorescent light. Phototherapy is a type of treatment that uses a specific light source. The most common treatment for a high bilirubin level in an infant is phototherapy (bright light therapy).  It efficiently treats neonatal jaundice by reducing bilirubin levels in the blood of the infant through a process known as photo-oxidation. LED phototherapy is more effective than current phototherapy methods. In order to execute phototherapy treatment, Neotech provides hospitals with a specific variety of neonatal care products.

It does not contain any harmful rays for your baby. Phototherapy is a very safe and effective treatment that can only be obtained in a hospital setting. When as much skin as possible is exposed to the light, the treatment works best.

Phototherapy Process

LED Phototherapy is used to treat jaundice in newborn infants that is caused by excessive levels of serum bilirubin, which can lead to chronic bilirubin encephalopathy (kernicterus). The skin and whites of the eyes of jaundiced newborns turn yellow. When Bilirubin absorbs light in this treatment, it is broken down into a molecule that the baby’s body can process and excrete. For newborn infants with jaundice, there are two options for treatment. One method is to place the newborns beneath halogen headlights with their eyes covered. A similar procedure involves exposing the newborns to fluorescent lamp lights. The use of bili lights to shine fluorescent light on naked skin is known as phototherapy. Bilirubin can be broken down into a form that the body can excrete through urine and stools by using a specific wavelength of light. Overall, this phototherapy procedure aids in the treatment of newborn jaundice by lowering bilirubin levels in the blood. Photo-oxidation is the name for this process. 

LED Phototherapy has the following purposes:

When it comes to infant hyperbilirubinemia, LED phototherapy is always the only option. Its success in lowering bilirubin levels on the infant’s exposed skin is due to light interaction with bilirubin at the skin level, which converts it to a water soluble discharge. This substance is then excreted in the urine and faeces, bypassing the liver’s metabolic process.

The approach of phototherapy devices has changed in recent years, moving away from fluorescent lights and toward LEDs, which increases the quantity of light energy emitted on a smaller surface.

Most term and preterm babies will have elevated levels of unconjugated bilirubin and moderate jaundice in the first weeks of their lives due to increasing levels of unconjugated bilirubin. This is a common occurrence in this age group, and it is especially common among premature babies. Untreated high levels of unconjugated bilirubin, on the other hand, can result in irreversible brain damage known as kernicterus.

This blue light phototherapy breaks down bilirubin in the blood, allowing the newborn to excrete the excess bilirubin without causing lasting brain damage (kernicterus) or death.

Advantages:

Treatment with blue light phototherapy is essential to avoid morbidity and mortality from high levels of newborn jaundice. Blue light absorbs bilirubin, which is subsequently broken down in the blood, allowing the newborn to eliminate excess bilirubin without it building up in the blood and causing lifelong brain damage or death. Jaundice can be prevented and treated.

However, some problems, such as kernicterus (brain injury), are chronic and irreversible, resulting in lifelong impairment.